The Role of Noninvasive Endpoints in Predicting Long-Term Outcomes in Pulmonary Arterial Hypertension.

Samantha L WronskiMargaret MordinKim KelleyRebekah H AnguianoPeter ClassiEric ShenScott Manaker

Published in: Lung (2019)

Assessment of 6MWD, FC, and BNP/NT-proBNP provides low-cost, efficient, and noninvasive means of predicting long-term health and economic outcomes in patients with PAH.

Keyphrases

pulmonary arterial hypertension
low cost
pulmonary artery
pulmonary hypertension
healthcare
public health
mental health
health information
coronary artery
social media
human health
risk assessment
climate change